CHRISTOFFERSEN RALPH E 4

4 · SEROLOGICALS CORP · Filed Sep 28, 2004

Form 4

Period: 2004-09-24

Director

Transactions

Exercise/Conversion
Common Stock, $0.01 par value
2004-09-24$11.62/sh+4,657$54,114→ 9,824.2 total
Exercise/Conversion
Common Stock, $0.01 par value
2004-09-24$23.55/sh+5,050$118,928→ 10,217.2 total
ConversionSwap
Stock Option
2004-09-24−293→ 27,918 total
Exercise: $11.62From: 2007-12-31Exp: 2009-05-15→ Common Stock, $0.01 Par Value (293 underlying)
Conversion
Stock Option
2004-09-24−5,050→ 27,918 total
Exercise: $11.62From: 2007-12-31Exp: 2009-05-15→ Common Stock, $0.01 Par Value (5,050 underlying)
Sale
Common Stock, $0.01 par value
2004-09-24$23.76/sh−293$6,962→ 5,167.2 total
Exercise/Conversion
Common Stock, $0.01 par value
2004-09-24$11.62/sh+293$3,405→ 5,460.2 total
Sale
Common Stock, $0.01 par value
2004-09-24$23.73/sh−4,657$110,511→ 5,167.2 total
ConversionSwap
Stock Option
2004-09-24−4,657→ 27,918 total
Exercise: $11.62From: 2007-12-31Exp: 2009-05-15→ Common Stock, $0.01 Par Value (4,657 underlying)

Footnotes (2)

[F1]Shares under stock option grant dated 5/15/2003 exercised and held.
[F2]Includes 5167.2 rights to shares of Common Stock earned as a result of deferring fees earned while serving as a Director of the Company. The shares are issuable upon the last day of service as a Director of the Company.

Documents

2 files